Cargando…

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review

BACKGROUND: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an uncommon neurological disease affecting the central nervous system (CNS). Numerous neurological disorders, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), acute transverse mye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirmosayyeb, Omid, Ghaffary, Elham Moases, Dehghan, Mohammad S., Ghoshouni, Hamed, Bagherieh, Sara, Barzegar, Mahdi, Shaygannejad, Vahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	COVID-19 – Advances, Challenges and Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063869/ https://www.ncbi.nlm.nih.gov/pubmed/37008248 http://dx.doi.org/10.1177/11795735231167869

Ejemplares similares

COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis
por: Yazdani, Amid, et al.
Publicado: (2022)

Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Neurosarcoidosis in an adult man with a family history of MS: A case report
por: Mirmosayyeb, Omid, et al.
Publicado: (2023)

Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
por: Vaheb, Saeed, et al.
Publicado: (2023)

Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis following third dose of BNT162b2 COVID-19 vaccine in a patient with systemic lupus erythematosus
por: Kang, Minsung, et al.
Publicado: (2023)

Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as Intracranial Hypertension: A Case Report
por: Chaudhuri, Jaydip Ray, et al.
Publicado: (2022)

Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)

COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022)

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study
por: Barzegar, Mahdi, et al.
Publicado: (2022)

Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Unraveling the Mystery of COVID-19 Postvaccination Myocarditis: A Systematic Review of Current Cases
por: Ghoshouni, Hamed, et al.
Publicado: (2022)

Parkinson’s disease and COVID-19: a systematic review and meta-analysis
por: Khoshnood, Reza Jalili, et al.
Publicado: (2021)

Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Screening neuromyelitis optica patients for COVID-19 infection
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
por: Nehzat, Nasim, et al.
Publicado: (2021)

Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study
por: Barzegar, Mahdi, et al.
Publicado: (2023)

Experimental Models of SARS-COV-2 Infection in the Central Nervous System
por: Paoletti, Anna Maria, et al.
Publicado: (2022)

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
por: Nakajima, Hideki, et al.
Publicado: (2015)

Limbic Encephalitis with Anti-myelin Oligodendrocyte Glycoprotein Antibody
por: Takasone, Ken, et al.
Publicado: (2020)

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
por: Barzegar, Mahdi, et al.
Publicado: (2021)

Characteristics of COVID-19 disease in multiple sclerosis patients
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
por: Ramanathan, Sudarshini, et al.
Publicado: (2014)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Gray Matter Encephalomyelitis with Anti-Myelin Oligodendrocyte Glycoprotein Antibody
por: Morizumi, Teruya, et al.
Publicado: (2020)

Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease
por: Kim, Hyunjin, et al.
Publicado: (2020)

Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease with Frequent Cerebellitis
por: Ishikura, Teruyuki, et al.
Publicado: (2022)

The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
por: Lerch, Magdalena, et al.
Publicado: (2023)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
por: Perez-Giraldo, Gina, et al.
Publicado: (2023)

COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)

Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset
por: Sadeghi-Bahmani, Dena, et al.
Publicado: (2022)

Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients
por: Mokhtari, Shahrzad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9d3vlrudhq5ivp2oqd0j0lopgo